Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience

Heart Rhythm. 2012 Dec;9(12):1954-61. doi: 10.1016/j.hrthm.2012.08.006. Epub 2012 Aug 4.

Abstract

Background: A medical device advisory issued by St Jude Medical in November 2011 estimated 0.63% all-cause abrasion rate on their Riata and Riata ST silicone high-voltage lead families (Riata/ST), leading to Food and Drug Administration class I recall. We performed an independent comparative, long-term electrical survival analysis of Riata/ST and 3 other high-voltage lead families in a large national cohort of patients.

Objective: To evaluate long-term electrical survival of Riata/ST leads relative to other commonly evaluated high-voltage leads.

Methods: Failure rates of Riata/ST, Sprint Quattro Secure (Quattro), Sprint Fidelis (Fidelis), and Endotak Reliance G/SG (Endotak) leads from the Veterans Administration's National Cardiac Device Surveillance Center database, consisting of 24,145 patients with remote transmissions since 2003, were analyzed. Survival Probabilities were determined with Kaplan-Meier survival analysis and compared using the log-rank test.

Results: Of 1,403 Riata/ST, 6,091 Quattro, 5,073 Fidelis, and 2,401 Endotak leads identified, 5-year survival probability of Riata/ST leads (97.5%) was significantly lower than that of Quattro (99.3%) and Endotak (99.4%) leads (P <.0001) but higher than that of Fidelis leads (89.6%) (P <.0001). Riata ST leads showed a 5-year survival of 95.5% (95% confidence interval 92.4-97.4) compared to 98.4% (95% confidence interval 97.1-99.1) in Riata leads (P = .003).

Conclusions: There is decreased survival probability of Riata/ST leads compared to other contemporary high-voltage leads, with decreased survival of Riata ST silicone compared to Riata lead series. Careful long-term follow-up should be maintained in patients with Riata/ST leads in order to prevent inappropriate shocks or failed device interventions. Our results were determined in advance of Food and Drug Administration class I recall, which suggested that large-scale remote monitoring may be an effective tool for continued implantable cardioverter-defibrillator system surveillance.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / mortality*
  • Arrhythmias, Cardiac / therapy
  • Defibrillators, Implantable*
  • Electrodes, Implanted*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Silicones*
  • Survival Rate / trends
  • United States / epidemiology
  • United States Department of Veterans Affairs / statistics & numerical data*
  • Veterans / statistics & numerical data*

Substances

  • Silicones